Patents by Inventor Richard Johnsson
Richard Johnsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11919921Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: GrantFiled: May 19, 2022Date of Patent: March 5, 2024Assignee: GALECTO BIOTECH ABInventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
-
Publication number: 20230391841Abstract: The present disclosure relates to the field of unconventional neurotrophic factors and to the field of treating degenerative, chronic or progressive diseases and disorders, and monogenic hereditary diseases having ER stress as a pathogenic compound. More particularly the disclosure relates to modified peptides, particularly macrocyclic peptides. The disclosure also relates to pharmaceutical compositions comprising said peptides. Further, the disclosure also relates to said peptides, and pharmaceutical compositions for use as a medicament and in the treatment of degenerative, chronic or progressive diseases and disorders, and monogenic hereditary diseases having ER stress as a pathogenic compound as well as to methods for treating said diseases and disorders.Type: ApplicationFiled: December 17, 2020Publication date: December 7, 2023Inventors: Henri HUTTUNEN, Arnab BHATTACHARJEE, Richard JOHNSSON, Maria VOLKOVA, Natalia KULESSKAYA
-
Publication number: 20220289783Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: ApplicationFiled: May 19, 2022Publication date: September 15, 2022Applicant: Galecto Biotech ABInventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
-
Patent number: 11377464Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: GrantFiled: September 11, 2020Date of Patent: July 5, 2022Assignee: Galecto Biotech ABInventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
-
Publication number: 20200407391Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: ApplicationFiled: September 11, 2020Publication date: December 31, 2020Applicant: Galecto Biotech ABInventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
-
Patent number: 10774102Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: GrantFiled: January 28, 2016Date of Patent: September 15, 2020Assignee: Galecto Biotech ABInventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
-
Patent number: 10730902Abstract: The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: GrantFiled: November 8, 2016Date of Patent: August 4, 2020Assignee: GALECTO BIOTECH ABInventors: Fredrik Zetterberg, Ulf Nilsson, Hakon Leffler, Anders Pedersen, Hans Schambye, Thomas Brimert, Richard Johnsson
-
Patent number: 10526360Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: GrantFiled: August 13, 2019Date of Patent: January 7, 2020Assignee: Galecto Biotech ABInventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
-
Publication number: 20190359643Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: ApplicationFiled: August 13, 2019Publication date: November 28, 2019Applicant: Galecto Biotech ABInventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
-
Patent number: 10464964Abstract: An Embodiment of the invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: GrantFiled: January 14, 2016Date of Patent: November 5, 2019Assignee: Galecto Biotech ABInventors: Fredrik Zetterberg, Ulf Nilsson, Hakon Leffler, Thomas Brimert, Richard Johnsson, Priya Verma
-
Publication number: 20180327440Abstract: The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: ApplicationFiled: November 8, 2016Publication date: November 15, 2018Applicant: GALECTO BIOTECH ABInventors: Fredrik ZETTERBERG, Ulf NILSSON, Hakon LEFFLER, Anders PEDERSEN, Hans SCHAMBYE, Thomas BRIMERT, Richard JOHNSSON
-
Publication number: 20170349619Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: ApplicationFiled: January 28, 2016Publication date: December 7, 2017Applicant: Galecto Biotech ABInventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
-
Publication number: 20170334940Abstract: An Embodiment of the invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.Type: ApplicationFiled: January 14, 2016Publication date: November 23, 2017Applicant: Galecto Biotech ABInventors: Fredrik ZETTERBERG, Ulf NILSSON, Hakon LEFFLER, Thomas BRIMERT, Richard JOHNSSON, Priya VERMA
-
Patent number: 8364917Abstract: A method for replicating a deduplicated storage system is disclosed. A stream of data is stored on an originator deduplicating system by storing a plurality of deduplicated segments and information on how to reconstruct the stream of data. The originator deduplicating system is replicated on a replica system by sending a copy of the plurality of deduplicated segments and information on how to reconstruct the stream of data to the replica system. A first portion of the deduplicated segments stored on the originator deduplicating system that is corrupted is identified. A copy of the first portion of the deduplicated segments is requested to be sent by the replica system to the originator deduplicating system.Type: GrantFiled: April 2, 2012Date of Patent: January 29, 2013Assignee: EMC CorporationInventors: Allan J. Bricker, Richard Johnsson, Greg Wade
-
Publication number: 20120191931Abstract: A method for replicating a deduplicated storage system is disclosed. A stream of data is stored on an originator deduplicating system by storing a plurality of deduplicated segments and information on how to reconstruct the stream of data. The originator deduplicating system is replicated on a replica system by sending a copy of the plurality of deduplicated segments and information on how to reconstruct the stream of data to the replica system. A first portion of the deduplicated segments stored on the originator deduplicating system that is corrupted is identified. A copy of the first portion of the deduplicated segments is requested to be sent by the replica system to the originator deduplicating system.Type: ApplicationFiled: April 2, 2012Publication date: July 26, 2012Applicants: EMC CORPORATIONInventors: Allan J. Bricker, Richard Johnsson, Greg Wade
-
Patent number: 8176277Abstract: A method of replicating a deduplicated storage system is disclosed. The method comprises storing a stream of data on an originator deduplicating system by storing deduplicated segments and information on how to reconstruct the stream of data. The method further comprises replicating the originator deduplicating system by receiving a copy of the deduplicated segments, information regarding containers for the deduplicated segments, and information on how to reconstruct the stream of data transferred from the originator deduplicating system to the replica system.Type: GrantFiled: August 24, 2011Date of Patent: May 8, 2012Assignee: EMC CorporationInventors: Allan J. Bricker, Richard Johnsson, Greg Wade
-
Publication number: 20110307441Abstract: A method of replicating a deduplicated storage system is disclosed. The method comprises storing a stream of data on an originator deduplicating system by storing deduplicated segments and information on how to reconstruct the stream of data. The method further comprises replicating the originator deduplicating system by receiving a copy of the deduplicated segments, information regarding containers for the deduplicated segments, and information on how to reconstruct the stream of data transferred from the originator deduplicating system to the replica system.Type: ApplicationFiled: August 24, 2011Publication date: December 15, 2011Applicants: EMC CORPORATIONInventors: Allan J. Bricker, Richard Johnsson, Greg Wade
-
Patent number: 8028138Abstract: A method of replicating a deduplicated storage system is disclosed. The method comprises requesting the state of a replica system. The method further comprises sending a container to the replica system and sending a file system log record to the replica system.Type: GrantFiled: July 24, 2009Date of Patent: September 27, 2011Assignee: EMC CorporationInventors: Allan J. Bricker, Richard Johnsson, Greg Wade
-
Patent number: 7747581Abstract: A network file system-based data storage system that converts random I/O requests into a piecewise sequential data structure to facilitate variable length data segment redundancy identification and elimination. For one embodiment of the invention a stateless network file system is employed. For one such embodiment, that provides multiple-client access to stored data, multiple Writes are buffered and then broken into variable length data segments. Redundant segment elimination is then effected. One embodiment of the invention allows sharing of the variable length data segments among files.Type: GrantFiled: April 19, 2007Date of Patent: June 29, 2010Assignee: EMC CorporationInventors: Kai Li, R. Hugo Patterson, Ming Benjamin Zhu, Allan Bricker, Richard Johnsson, Sazzala Reddy, Jeffery Zabarsky
-
Patent number: 7689633Abstract: A network file system-based data storage system that converts random I/O requests into a piecewise sequential data structure to facilitate variable length data segment redundancy identification and elimination. For one embodiment of the invention a stateless network file system is employed. For one such embodiment, that provides multiple-client access to stored data, multiple Writes are buffered and then broken into variable length data segments. Redundant segment elimination is then effected. One embodiment of the invention allows sharing of the variable length data segments among files.Type: GrantFiled: September 15, 2004Date of Patent: March 30, 2010Assignee: Data Domain, Inc.Inventors: Kai Li, R. Hugo Patterson, Ming Benjamin Zhu, Allan Bricker, Richard Johnsson, Sazzala Reddy, Jeffery Zabarsky